Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
Perotti V, Baldassari P, Molla A, Vegetti C, Bersani I, Maurichi A, Santinami M, Anichini A, Mortarini R. Perotti V, et al. Among authors: vegetti c. Oncogene. 2016 Jun 2;35(22):2862-72. doi: 10.1038/onc.2015.355. Epub 2015 Sep 21. Oncogene. 2016. PMID: 26387540
Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways.
Tassi E, Zanon M, Vegetti C, Molla A, Bersani I, Perotti V, Pennati M, Zaffaroni N, Milella M, Ferrone S, Carlo-Stella C, Gianni AM, Mortarini R, Anichini A. Tassi E, et al. Among authors: vegetti c. Clin Cancer Res. 2012 Jun 15;18(12):3316-27. doi: 10.1158/1078-0432.CCR-11-2232. Epub 2012 May 2. Clin Cancer Res. 2012. PMID: 22553342 Free PMC article.
NFATc2 is a potential therapeutic target in human melanoma.
Perotti V, Baldassari P, Bersani I, Molla A, Vegetti C, Tassi E, Dal Col J, Dolcetti R, Anichini A, Mortarini R. Perotti V, et al. Among authors: vegetti c. J Invest Dermatol. 2012 Nov;132(11):2652-60. doi: 10.1038/jid.2012.179. Epub 2012 Jun 21. J Invest Dermatol. 2012. PMID: 22718120 Free article.
22 results